# Adequate Dosage of Sugammadex on Thyroid Surgery

> **NCT03689413** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 102 (actual)

## Conditions studied

- Thyroid Surgery

## Interventions

- **DRUG:** Sugammadex 200 MG in 2 ML Injection

## Key facts

- **NCT ID:** NCT03689413
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2019-08-28
- **Final completion:** 2019-08-28
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2020-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03689413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03689413, "Adequate Dosage of Sugammadex on Thyroid Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03689413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*